EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudieOpen Access · CC BY-NC-ND 4.0

Large-Bore Mechanical Thrombectomy Versus Catheter-Directed Thrombolysis in the Management of Intermediate-Risk Pulmonary Embolism: Primary Results of the PEERLESS Randomized Controlled Trial

Wissam A Jaber iD, Carin F Gonsalves, Stefan Stortecky iD, Samuel Horr, Orestis Pappas iD, Ripal T Gandhi, Keith Pereira, Jay Giri iD, Sameer J Khandhar, Khawaja Afzal Ammar iD, David M Lasorda, Brian Stegman iD und 29 weitere

Circulation · 04.02.2025 · 151 (5) · 260-273

DOI: 10.1161/circulationaha.124.072364 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Circulation, erschienen am 04.02.2025. Verfasst von Wissam A Jaber und 40 weiteren Autor:innen. Beteiligte Einrichtung: Emory University Hospital, Atlanta, GA (W.A.J.). Hauptthemen laut MEDLINE: Pulmonary Embolism, Thrombolytic Therapy, Thrombectomy. Die Arbeit wurde bisher 221-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Inari Medical.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: There are a lack of randomized controlled trial data comparing outcomes of different catheter-based interventions for intermediate-risk pulmonary embolism. METHODS: PEERLESS is a prospective, multicenter, randomized controlled trial that enrolled 550 patients with intermediate-risk pulmonary embolism with right ventricular dilatation and additional clinical risk factors randomized 1:1 to treatment with large-bore mechanical thrombectomy (LBMT) or catheter-directed thrombolysis (CDT). The primary end point was a hierarchal win ratio composite of the following (assessed at the sooner of hospital discharge or 7 days after the procedure): (1) all-cause mortality, (2) intracranial hemorrhage, (3) major bleeding, (4) clinical deterioration and/or escalation to bailout, and (5) postprocedural intensive care unit admission and length of stay. Assessments at the 24-hour visit included respiratory rate, modified Medical Research Council dyspnea score, New York Heart Association classification, right ventricle/left ventricle ratio reduction, and right ventricular function. End points through 30 days included total hospital stay, all-cause readmission, and all-cause mortality. RESULTS: The primary end point occurred significantly less frequently with LBMT compared with CDT (win ratio, 5.01 [95% CI, 3.68–6.97]; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary EmbolismThrombolytic TherapyThrombectomyHumansMaleFemaleMiddle AgedAgedProspective StudiesTreatment OutcomeRisk FactorsLength of StayFibrinolytic Agents

Stichwörter der Autor:innen

percutaneous aspirationpulmonary embolismrandomized controlled trialthrombectomythrombolytic therapy

Substanzen

Fibrinolytic Agents

Autor:innen und Institutionen

  • Emory University Hospital, Atlanta, GA (W.A.J.).
  • Thomas Jefferson University Hospitals, Philadelphia, PA (C.F.G.).
  • Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Switzerland (S. Stortecky).
  • Centennial Medical Center, Nashville, TN (S.H.).
  • Allegheny Health Network, Erie, PA (O.P.).
  • Miami Cardiac and Vascular Institute, Baptist Health South Florida (R.T.G.).

ORCID-Profile: Wissam A Jaber, Stefan Stortecky, Orestis Pappas, Jay Giri, Khawaja Afzal Ammar, Brian Stegman, Lucas Busch, Ezana M Azene, Fakhir Elmasri, Mark E Rea, Joseph Campbell, Jonathan Lindquist, Gabriel A Hernandez, Parth Rali, Jeffrey T Bruckel, Juan C Camacho, Jun Li, Brian A Bergmark, Bhavraj Khalsa, David J O'Connor, C Michael Gibson

Förderung

  • Inari Medical

Zitieren

APA

Jaber, W. A., Gonsalves, C. F., Stortecky, S., Horr, S., Pappas, O., Gandhi, R. T., Pereira, K., Giri, J., Khandhar, S. J., Ammar, K. A., Lasorda, D. M., Stegman, B., Busch, L., Dexter, D. J., Azene, E. M., Daga, N., Elmasri, F., Kunavarapu, C. R., Rea, M. E., …, & PEERLESS Committees and Investigators* (2025). Large-Bore Mechanical Thrombectomy Versus Catheter-Directed Thrombolysis in the Management of Intermediate-Risk Pulmonary Embolism: Primary Results of the PEERLESS Randomized Controlled Trial. Circulation, 151(5), 260-273. https://doi.org/10.1161/circulationaha.124.072364

Vancouver

Jaber WA, Gonsalves CF, Stortecky S, Horr S, Pappas O, Gandhi RT, et al. Large-Bore Mechanical Thrombectomy Versus Catheter-Directed Thrombolysis in the Management of Intermediate-Risk Pulmonary Embolism: Primary Results of the PEERLESS Randomized Controlled Trial. Circulation. 2025;151(5):260-273. doi:10.1161/circulationaha.124.072364

BibTeX
@article{Jaber2025,
  author = {Jaber, Wissam A and Gonsalves, Carin F and Stortecky, Stefan and Horr, Samuel and Pappas, Orestis and Gandhi, Ripal T and Pereira, Keith and Giri, Jay and Khandhar, Sameer J and Ammar, Khawaja Afzal and Lasorda, David M and Stegman, Brian and Busch, Lucas and Dexter, David J and Azene, Ezana M and Daga, Nikhil and Elmasri, Fakhir and Kunavarapu, Chandra R and Rea, Mark E and Rossi, Joseph S and Campbell, Joseph and Lindquist, Jonathan and Raskin, Adam and Smith, Jason C and Tamlyn, Thomas M and Hernandez, Gabriel A and Rali, Parth and Schmidt, Torrey R and Bruckel, Jeffrey T and Camacho, Juan C and Li, Jun and Selim, Samy and Toma, Catalin and Basra, Sukhdeep Singh and Bergmark, Brian A and Khalsa, Bhavraj and Zlotnick, David M and Castle, Jordan and O'Connor, David J and Gibson, C Michael and PEERLESS Committees and Investigators*, PEERLESS Committees and Investigators*},
  title = {Large-Bore Mechanical Thrombectomy Versus Catheter-Directed Thrombolysis in the Management of Intermediate-Risk Pulmonary Embolism: Primary Results of the PEERLESS Randomized Controlled Trial},
  journal = {Circulation},
  year = {2025},
  volume = {151},
  number = {5},
  pages = {260--273},
  doi = {10.1161/circulationaha.124.072364}
}
Kostenlos starten →